A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102

NCT03613662 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Lumbosacral Radicular Pain

Interventions

DRUG: SP-102

Sponsor

Semnur Pharmaceuticals, Inc.

Collaborators

[object Object]
[object Object]